Benny T. Hu
Chairman
pharmaceutical
Senhwa Biosciences
Singapore
Biography
Mr. Hu is a well-known entrepreneur and also a professional manager with proactive thinking. He has been investing in China since 1996 starting while he was leading China Development Industrial Bank (CDIB). During the period of 1993-2004, he grew the investment portfolio from $ 250MM to $ 3.0Bn, making CDIB one of Asia′s largest investment companies. He expanded business of the bank to the United States, Great Britain, Japan, Hong Kong, Korea, Australia, and Philippines. Of the 250 companies invested during tenure, 62 companies had IPOs and 10 were acquired. In 2003, he assumed role as Chairman and Director of Taipei 101, the tallest building in the world when completed in 2004. Mr. Hu is currently Chairman of Senhwa Biosciences, Inc. dedicating to develop first-in-class small molecule drugs used in cancer treatments. Mr. Hu received a BA from National Taiwan University, an MA from Yale University and an MBA from Wharton School of University of Pennsylvania.
Research Interest
Small molecule drugs used in cancer treatments.